AfroCentric Investment Corporation Limited (JSE:ACT)
South Africa
· Delayed Price · Currency is ZAR · Price in ZAc 136.00
-4.00 (-2.86%)
At close: Dec 5, 2025
JSE:ACT Revenue
AfroCentric Investment Corporation had revenue of 4.28B ZAR in the half year ending June 30, 2025, a decrease of -2.45%. This brings the company's revenue in the last twelve months to 8.48B, down -4.81% year-over-year. In the year 2024, AfroCentric Investment Corporation had annual revenue of 8.60B, down -3.44%.
Revenue (ttm)
8.48B
Revenue Growth
-4.81%
P/S Ratio
0.13
Revenue / Employee
1.54M
Employees
5,503
Market Cap
1.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.60B | -305.96M | -3.44% |
| Jun 30, 2024 | 8.90B | 53.32M | 0.60% |
| Jun 30, 2023 | 8.85B | 155.52M | 1.79% |
| Jun 30, 2022 | 8.69B | 616.30M | 7.63% |
| Jun 30, 2021 | 8.08B | 1.66B | 25.84% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Clicks Group | 47.83B |
| Aspen Pharmacare Holdings | 43.36B |
| Dis-Chem Pharmacies | 40.88B |
| Netcare | 26.34B |
| Life Healthcare Group Holdings | 25.40B |
| Ascendis Health | 734.49M |
| Labat Africa | 199.40M |